1. Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation
   Huy Hoang Dang et al, 2022, Functional & Integrative Genomics CrossRef
2. Oncogenic Targets Regulated by Tumor-Suppressive miR-30c-1-3p and miR-30c-2-3p: TRIP13 Facilitates Cancer Cell Aggressiveness in Breast Cancer
   Reiko Mitsueda et al, 2023, Cancers CrossRef
3. Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13)
   Xavier Bossuyt et al, 2023, Autoimmunity Reviews CrossRef
4. Regulation of apoptosis, autophagy and ferroptosis by non‑coding RNAs in metastatic non‑small cell lung cancer (Review)
   Lei Xu et al, 2022, Experimental and Therapeutic Medicine CrossRef
5. Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine
   Vigneshwar Suriya Prakash Sinnarasan et al, 2023, OMICS: A Journal of Integrative Biology CrossRef
6. Mitophagy-related gene signature for predicting the prognosis of multiple myeloma
   Tiange Lv et al, 2024, Heliyon CrossRef
7. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation
   Renguo Guan et al, 2022, BMC Cancer CrossRef
8. miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response
   Mehrdad Hashemi et al, 2023, Pathology - Research and Practice CrossRef
9. Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
   Karuna Mittal et al, 2024, Communications Biology CrossRef